E. Baader

567 total citations
15 papers, 441 citations indexed

About

E. Baader is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, E. Baader has authored 15 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in E. Baader's work include Microbial Natural Products and Biosynthesis (3 papers), Plant biochemistry and biosynthesis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). E. Baader is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Plant biochemistry and biosynthesis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). E. Baader collaborates with scholars based in Germany, United States and Finland. E. Baader's co-authors include Heiner Jendralla, Wilhelm Bartmann, G. Beck, Volkmar Günzler, Kurt Keßeler, E. Granzer, R. A. Krause, Georg Tschank, B. v. Kerékjártó and Andreas Bergmann and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

E. Baader

15 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Baader Germany 12 210 141 103 83 69 15 441
E. Granzer Germany 12 200 1.0× 189 1.3× 121 1.2× 87 1.0× 22 0.3× 29 478
Kau-Ming Chen United States 8 165 0.8× 435 3.1× 142 1.4× 117 1.4× 21 0.3× 12 548
Sarah C. Traeger United States 13 149 0.7× 224 1.6× 71 0.7× 61 0.7× 26 0.4× 26 464
Michael C. Matelich United States 7 211 1.0× 335 2.4× 104 1.0× 104 1.3× 32 0.5× 9 606
João F. S. Carvalho Portugal 9 287 1.4× 182 1.3× 59 0.6× 45 0.5× 25 0.4× 12 522
Steven A. Boyd United States 18 322 1.5× 320 2.3× 63 0.6× 27 0.3× 25 0.4× 34 739
Catherine Sekerke United States 16 278 1.3× 222 1.6× 70 0.7× 48 0.6× 67 1.0× 19 645
Rolf Jautelat Germany 12 250 1.2× 335 2.4× 73 0.7× 79 1.0× 35 0.5× 21 543
Darin J. Gustin United States 15 267 1.3× 253 1.8× 133 1.3× 31 0.4× 39 0.6× 20 548
Xiao‐Cong Huang Australia 11 145 0.7× 183 1.3× 114 1.1× 120 1.4× 35 0.5× 16 483

Countries citing papers authored by E. Baader

Since Specialization
Citations

This map shows the geographic impact of E. Baader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Baader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Baader more than expected).

Fields of papers citing papers by E. Baader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Baader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Baader. The network helps show where E. Baader may publish in the future.

Co-authorship network of co-authors of E. Baader

This figure shows the co-authorship network connecting the top 25 collaborators of E. Baader. A scholar is included among the top collaborators of E. Baader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Baader. E. Baader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Baader, E., M. Bickel, Douglas D Damm, et al.. (1994). Interference in Clinical Laboratory Tests, with Special Regard to the Bilirubin Assay: Effects of a Metabolite of the New Prolyl 4-Hydroxylase Inhibitor, Lufironil. Clinical Chemistry and Laboratory Medicine (CCLM). 32(7). 515–520. 4 indexed citations
2.
Baader, E., et al.. (1994). Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochemical Journal. 300(2). 525–530. 58 indexed citations
3.
Jendralla, Heiner, E. Granzer, B. v. Kerékjártó, et al.. (1991). Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids. Journal of Medicinal Chemistry. 34(10). 2962–2983. 43 indexed citations
4.
Bickel, M., et al.. (1991). Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. Journal of Hepatology. 13. S26–S34. 34 indexed citations
5.
6.
Wess, Günther, Kurt Keßeler, E. Baader, et al.. (1990). Stereoselective synthesis of HR 780 a new highly potent HMG-CoA reductase inhibitor. Tetrahedron Letters. 31(18). 2545–2548. 59 indexed citations
7.
Beck, G., Kurt Keßeler, E. Baader, et al.. (1990). Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids. Journal of Medicinal Chemistry. 33(1). 52–60. 57 indexed citations
8.
Jendralla, Heiner, E. Baader, Wilhelm Bartmann, et al.. (1990). Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids. Journal of Medicinal Chemistry. 33(1). 61–70. 48 indexed citations
9.
10.
Baader, E., Wilhelm Bartmann, G. Beck, et al.. (1989). Enantioselective synthesis of a new fluoro-substituted HMG-COA reductase inhibitor. Tetrahedron Letters. 30(38). 5115–5118. 19 indexed citations
11.
Baader, E., Wilhelm Bartmann, G. Beck, et al.. (1988). Synthesis of a novel HMG-COA reductase inhibitor. Tetrahedron Letters. 29(8). 929–930. 12 indexed citations
12.
Baader, E., Wilhelm Bartmann, G. Beck, et al.. (1988). Syntheses of 4(R)-silyloxy-6(S)-iodomethyl-tetrahydropyran-2-one and its enantiomer, building blocks for HMG-COA reductase inhibitors. Tetrahedron Letters. 29(21). 2563–2565. 22 indexed citations
13.
Hanauske‐Abel, Hartmut M., Georg Tschank, Volkmar Günzler, E. Baader, & Paul M. Gallop. (1987). Pyrroloquinoline quinone and molecules mimicking its functional domains Modulators of connective tissue formation?. FEBS Letters. 214(2). 236–243. 11 indexed citations
14.
Hütter, Klaus, E. Baader, Axel Zeeck, et al.. (1986). Viriplanin A, a new anthracycline antibiotic of the nogalamycin group. I Isolation, characterization, degradation reactions and biological properties.. The Journal of Antibiotics. 39(9). 1193–1204. 19 indexed citations
15.
Baader, E.. (1951). Die chronische Kadmiumvergiftung. DMW - Deutsche Medizinische Wochenschrift. 76(14). 484–487. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Granzer Breakdown of academic impact, for papers by Kau-Ming Chen Breakdown of academic impact, for papers by Sarah C. Traeger Breakdown of academic impact, for papers by Michael C. Matelich Breakdown of academic impact, for papers by João F. S. Carvalho Breakdown of academic impact, for papers by Steven A. Boyd Breakdown of academic impact, for papers by Catherine Sekerke Breakdown of academic impact, for papers by Rolf Jautelat Breakdown of academic impact, for papers by Darin J. Gustin Breakdown of academic impact, for papers by Xiao‐Cong Huang
Rankless by CCL
2026